| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 11 | 2024 | 172 | 2.970 |
Why?
|
| Aerospace Medicine | 4 | 2022 | 39 | 0.940 |
Why?
|
| Human Experimentation | 1 | 2023 | 32 | 0.810 |
Why?
|
| Research Subjects | 1 | 2023 | 53 | 0.790 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 13 | 0.750 |
Why?
|
| Radiation Protection | 1 | 2022 | 49 | 0.740 |
Why?
|
| Radiation Exposure | 1 | 2022 | 43 | 0.720 |
Why?
|
| Head-Down Tilt | 5 | 2018 | 26 | 0.670 |
Why?
|
| Psychiatry | 1 | 2023 | 272 | 0.640 |
Why?
|
| Intracranial Pressure | 4 | 2018 | 215 | 0.620 |
Why?
|
| Astronauts | 5 | 2024 | 79 | 0.610 |
Why?
|
| Weightlessness | 4 | 2024 | 86 | 0.590 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 135 | 0.550 |
Why?
|
| Urologic Surgical Procedures | 1 | 2017 | 62 | 0.520 |
Why?
|
| Membrane Proteins | 12 | 2006 | 1610 | 0.510 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2015 | 14 | 0.470 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 113 | 0.460 |
Why?
|
| Embryonic and Fetal Development | 3 | 1999 | 126 | 0.430 |
Why?
|
| Carbon Dioxide | 4 | 2018 | 272 | 0.400 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 403 | 0.350 |
Why?
|
| Brain | 5 | 2023 | 3236 | 0.350 |
Why?
|
| Proteins | 4 | 2001 | 1027 | 0.320 |
Why?
|
| Monitoring, Physiologic | 3 | 2024 | 371 | 0.260 |
Why?
|
| Receptors, Cell Surface | 4 | 2002 | 432 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 487 | 0.210 |
Why?
|
| United States National Aeronautics and Space Administration | 2 | 2020 | 17 | 0.200 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.190 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 261 | 0.190 |
Why?
|
| Mars | 1 | 2021 | 2 | 0.170 |
Why?
|
| Proteinuria | 1 | 2001 | 106 | 0.170 |
Why?
|
| Unemployment | 1 | 2020 | 23 | 0.170 |
Why?
|
| Endopeptidases | 5 | 2005 | 108 | 0.160 |
Why?
|
| Mental Health | 1 | 2023 | 384 | 0.150 |
Why?
|
| Body Patterning | 1 | 1999 | 128 | 0.150 |
Why?
|
| Research Personnel | 1 | 2020 | 139 | 0.150 |
Why?
|
| Fetal Proteins | 1 | 1998 | 10 | 0.150 |
Why?
|
| Intraocular Pressure | 2 | 2017 | 132 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1999 | 96 | 0.140 |
Why?
|
| Mice | 19 | 2008 | 18484 | 0.140 |
Why?
|
| Presenilin-2 | 9 | 2006 | 19 | 0.140 |
Why?
|
| Animals | 22 | 2022 | 34410 | 0.140 |
Why?
|
| Pupil | 1 | 2018 | 47 | 0.140 |
Why?
|
| Helminth Proteins | 1 | 1998 | 104 | 0.140 |
Why?
|
| Transcription Factors | 4 | 2002 | 2438 | 0.140 |
Why?
|
| Jugular Veins | 1 | 2018 | 74 | 0.140 |
Why?
|
| Blood Volume | 1 | 2018 | 71 | 0.140 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1998 | 104 | 0.130 |
Why?
|
| Megakaryocytes | 1 | 1997 | 42 | 0.130 |
Why?
|
| Radiation-Protective Agents | 1 | 2017 | 17 | 0.130 |
Why?
|
| Humans | 23 | 2024 | 131784 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 324 | 0.130 |
Why?
|
| Hypercapnia | 1 | 2017 | 23 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2022 | 1224 | 0.130 |
Why?
|
| Cognition | 2 | 2024 | 845 | 0.130 |
Why?
|
| Rest | 1 | 2017 | 63 | 0.130 |
Why?
|
| Caenorhabditis elegans | 1 | 1998 | 251 | 0.130 |
Why?
|
| Myocardium | 2 | 2005 | 874 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 226 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 1997 | 204 | 0.120 |
Why?
|
| Urology | 1 | 2017 | 84 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 1996 | 64 | 0.120 |
Why?
|
| Presenilin-1 | 8 | 2005 | 52 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2017 | 146 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 1997 | 220 | 0.120 |
Why?
|
| Spinal Puncture | 1 | 2015 | 51 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 149 | 0.120 |
Why?
|
| Microbiota | 1 | 2021 | 441 | 0.110 |
Why?
|
| Signal Transduction | 6 | 2005 | 4682 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 149 | 0.110 |
Why?
|
| Reference Standards | 1 | 2015 | 231 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 682 | 0.110 |
Why?
|
| Kidney | 1 | 2001 | 1309 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 557 | 0.110 |
Why?
|
| Aspartic Acid Endopeptidases | 5 | 2005 | 31 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 1005 | 0.100 |
Why?
|
| ROC Curve | 1 | 2015 | 623 | 0.100 |
Why?
|
| Weightlessness Simulation | 3 | 2018 | 23 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2001 | 1130 | 0.100 |
Why?
|
| Health Status | 1 | 2014 | 388 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2001 | 3616 | 0.090 |
Why?
|
| Cross-Over Studies | 3 | 2017 | 332 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2001 | 1219 | 0.090 |
Why?
|
| Health Behavior | 1 | 2014 | 390 | 0.090 |
Why?
|
| Adult | 8 | 2024 | 31709 | 0.090 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1990 | 30 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1990 | 51 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 866 | 0.080 |
Why?
|
| Mitosis | 1 | 1990 | 190 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 1005 | 0.080 |
Why?
|
| Acetylcysteine | 2 | 2017 | 79 | 0.070 |
Why?
|
| Double-Blind Method | 3 | 2017 | 1638 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2002 | 356 | 0.070 |
Why?
|
| Thinness | 1 | 2008 | 71 | 0.070 |
Why?
|
| Base Sequence | 3 | 2001 | 2783 | 0.070 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 199 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 2565 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2000 | 2570 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 452 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2005 | 436 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 694 | 0.060 |
Why?
|
| Receptors, Notch | 4 | 2002 | 204 | 0.060 |
Why?
|
| Adiposity | 1 | 2008 | 207 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3838 | 0.060 |
Why?
|
| Glycoproteins | 1 | 1988 | 349 | 0.060 |
Why?
|
| Male | 9 | 2024 | 65293 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 2 | 2005 | 236 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 5 | 2005 | 59 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 495 | 0.060 |
Why?
|
| Systole | 1 | 2005 | 197 | 0.060 |
Why?
|
| Cell Line | 6 | 2005 | 2606 | 0.060 |
Why?
|
| Receptor, Notch1 | 3 | 2002 | 75 | 0.060 |
Why?
|
| Young Adult | 2 | 2018 | 10102 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 6509 | 0.050 |
Why?
|
| Middle Aged | 4 | 2018 | 28897 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2024 | 75 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 1990 | 2353 | 0.050 |
Why?
|
| Mice, Knockout | 7 | 2008 | 3864 | 0.050 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 13 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2003 | 56 | 0.050 |
Why?
|
| DNA Adducts | 1 | 2003 | 71 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2001 | 171 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 1069 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 262 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2001 | 236 | 0.040 |
Why?
|
| Time Factors | 4 | 2024 | 6280 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2005 | 2969 | 0.040 |
Why?
|
| Social Behavior | 1 | 2023 | 217 | 0.040 |
Why?
|
| Transfection | 4 | 2005 | 960 | 0.040 |
Why?
|
| Longevity | 1 | 2003 | 176 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 2001 | 104 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 515 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 39 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 33 | 0.040 |
Why?
|
| Calcium | 1 | 2005 | 1043 | 0.040 |
Why?
|
| Female | 6 | 2024 | 71224 | 0.040 |
Why?
|
| Exons | 1 | 2003 | 769 | 0.040 |
Why?
|
| Cataract | 1 | 2001 | 152 | 0.040 |
Why?
|
| Thrombospondins | 2 | 1990 | 14 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 173 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2000 | 178 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2000 | 114 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 589 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 421 | 0.040 |
Why?
|
| Hybrid Cells | 1 | 1999 | 78 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 1999 | 136 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 366 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2018 | 816 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 1998 | 80 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 41 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2018 | 7 | 0.040 |
Why?
|
| Breath Holding | 1 | 2018 | 7 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2005 | 4768 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 64 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 600 | 0.040 |
Why?
|
| Cytosol | 1 | 1998 | 140 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2001 | 1398 | 0.040 |
Why?
|
| Somites | 1 | 1997 | 8 | 0.030 |
Why?
|
| Nervous System | 1 | 1998 | 123 | 0.030 |
Why?
|
| Gene Library | 1 | 1998 | 213 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 1998 | 160 | 0.030 |
Why?
|
| Melanocytes | 1 | 1997 | 45 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 738 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 625 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1997 | 99 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 2017 | 20 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2017 | 36 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 595 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 754 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 3416 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 111 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 56 | 0.030 |
Why?
|
| Aged | 1 | 2015 | 21263 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2005 | 464 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 20994 | 0.030 |
Why?
|
| Bed Rest | 1 | 2017 | 24 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 989 | 0.030 |
Why?
|
| Cerebral Veins | 1 | 2017 | 22 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2017 | 28 | 0.030 |
Why?
|
| Obesity | 1 | 2008 | 2390 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 101 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1996 | 60 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2017 | 126 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2017 | 139 | 0.030 |
Why?
|
| DNA | 3 | 2005 | 1441 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1226 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 215 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 217 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1165 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 580 | 0.030 |
Why?
|
| Cell Division | 2 | 2002 | 731 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1024 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2006 | 191 | 0.030 |
Why?
|
| Metformin | 1 | 2017 | 168 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 302 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1996 | 400 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 784 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 786 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2000 | 2363 | 0.030 |
Why?
|
| Behavioral Research | 1 | 2014 | 17 | 0.030 |
Why?
|
| Blastocyst | 2 | 2005 | 78 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 274 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 1835 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 975 | 0.020 |
Why?
|
| Gene Expression | 1 | 1997 | 1502 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 2650 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 475 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 667 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 835 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1998 | 732 | 0.020 |
Why?
|
| United States | 2 | 2020 | 11814 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 1018 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 437 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3917 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2002 | 312 | 0.020 |
Why?
|
| Fibronectins | 1 | 1990 | 99 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 743 | 0.020 |
Why?
|
| Neurons | 3 | 2005 | 1995 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1610 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1626 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 723 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 1236 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1988 | 6 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1988 | 8 | 0.020 |
Why?
|
| Collagen | 1 | 1990 | 289 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 48 | 0.020 |
Why?
|
| Mutation | 4 | 2005 | 6194 | 0.020 |
Why?
|
| Endonucleases | 1 | 1988 | 51 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1988 | 127 | 0.020 |
Why?
|
| Protein Binding | 2 | 2002 | 1712 | 0.020 |
Why?
|
| Cattle | 1 | 1988 | 521 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 4528 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 276 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2006 | 70 | 0.020 |
Why?
|
| Ionophores | 1 | 2005 | 9 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2005 | 56 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 38 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 2005 | 19 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 37 | 0.010 |
Why?
|
| Carbamates | 1 | 2005 | 66 | 0.010 |
Why?
|
| Dipeptides | 1 | 2005 | 64 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2005 | 149 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 428 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 248 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 328 | 0.010 |
Why?
|
| Alzheimer Disease | 2 | 2003 | 875 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 803 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 416 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1104 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 373 | 0.010 |
Why?
|
| Affinity Labels | 1 | 2003 | 10 | 0.010 |
Why?
|
| Breeding | 1 | 2003 | 19 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 32 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2005 | 241 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2003 | 43 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 50 | 0.010 |
Why?
|
| Genes, BRCA2 | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 160 | 0.010 |
Why?
|
| Mitomycin | 1 | 2003 | 48 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 1202 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 286 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2002 | 14 | 0.010 |
Why?
|
| Leupeptins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 21 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 56 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 2656 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 11 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 41 | 0.010 |
Why?
|
| Osmosis | 1 | 2001 | 17 | 0.010 |
Why?
|
| Aquaporins | 1 | 2001 | 17 | 0.010 |
Why?
|
| Solubility | 1 | 2002 | 118 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 137 | 0.010 |
Why?
|
| Fluorometry | 1 | 2002 | 27 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 80 | 0.010 |
Why?
|
| Chimera | 1 | 2001 | 79 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 155 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 127 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 182 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 260 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 117 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 120 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 95 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2993 | 0.010 |
Why?
|
| Lasers | 1 | 2001 | 114 | 0.010 |
Why?
|
| Transcription Factor CHOP | 1 | 2000 | 5 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2000 | 48 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 1711 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2001 | 106 | 0.010 |
Why?
|
| Water | 1 | 2001 | 190 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 769 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 854 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 1395 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 486 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2001 | 234 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 566 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 450 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2002 | 286 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 215 | 0.010 |
Why?
|
| Homozygote | 1 | 2001 | 549 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 209 | 0.010 |
Why?
|
| DNA Damage | 1 | 2003 | 527 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1316 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 598 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 728 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 567 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2483 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2000 | 832 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 864 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4686 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 773 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2000 | 781 | 0.010 |
Why?
|
| Apoptosis | 1 | 2002 | 1860 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 2221 | 0.010 |
Why?
|
| Age Factors | 1 | 2001 | 2872 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1965 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 1948 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2000 | 1562 | 0.010 |
Why?
|